SUNPHARMA vs CIPLA: Stock Comparison
Head-to-head financial and trading comparison between Sun Pharmaceutical Industries Limited (SUNPHARMA) and Cipla Limited (CIPLA) in the Pharmaceuticals & Healthcare sector.
SUNPHARMA
NSE: SUNPHARMACIPLA
NSE: CIPLAKey Metrics Comparison Table
| Metric | SUNPHARMA | CIPLA | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹1,801.00 | ₹1,344.00 | — |
| 1-Year Price Return | +8.83% | +9.31% | CIPLA (0.48% higher) |
| 52-Week High | ₹2,001.10 | ₹1,477.00 | — |
| 52-Week Low | ₹1,620.40 | ₹1,211.10 | — |
| 30-Day Annualized Volatility | 19.94% | 15.13% | CIPLA (Steadier) |
| 30-Day Average Daily Volume | 1,593,973 | 912,248 | SUNPHARMA (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between SUNPHARMA and CIPLA, which stock gave better returns over the last year?
CIPLA has outperformed SUNPHARMA over the past 12 months with a gain of 9.31% compared to 8.83%.
Which stock is less volatile: SUNPHARMA or CIPLA?
CIPLA demonstrated lower price volatility (15.13% annualized) compared to SUNPHARMA (19.94%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of SUNPHARMA vs CIPLA?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are SUNPHARMA and CIPLA direct sector competitors?
Yes, both companies operate within the Pharmaceuticals & Healthcare sector in India and are actively tracked as sector peers by institutional and retail market participants.